{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:24:26Z","timestamp":1794288266983,"version":"4.9.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"8138","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,10,29]]},"DOI":"10.1038\/s41586-026-11002-8","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:02:11Z","timestamp":1788966131000},"page":"1330-1340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A serpin\u2013myeloid axis in pancreatic cancer heterogeneity and immune evasion"],"prefix":"10.1038","volume":"658","author":[{"given":"Chiara","family":"Falcomat\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6038-7847","authenticated-orcid":false,"given":"Maximilian M.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6641-6429","authenticated-orcid":false,"given":"Bhavya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Chhamalwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian R.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter T.","family":"Potak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Dhainaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkan","family":"Mollaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-3262","authenticated-orcid":false,"given":"Matthew D.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4481-7827","authenticated-orcid":false,"given":"Miriam","family":"Merad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Baccarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-8778","authenticated-orcid":false,"given":"Brian D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"11002_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho, W. J., Jaffee, E. M. & Zheng, L. The tumour microenvironment in pancreatic cancer \u2014 clinical challenges and opportunities. Nat. Rev. Clin. Oncol. 17, 527\u2013540 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"11002_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1158\/2159-8290.CD-22-0876","volume":"13","author":"C Falcomat\u00e0","year":"2023","unstructured":"Falcomat\u00e0, C. et al. Context-specific determinants of the immunosuppressive tumor microenvironment in pancreatic cancer. Cancer Discov. 13, 278\u2013297 (2023).","journal-title":"Cancer Discov."},{"key":"11002_CR3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M. & Maitra, A. Pancreatic cancer: advances and challenges. Cell 186, 1729\u20131754 (2023).","journal-title":"Cell"},{"key":"11002_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-025-00905-9","author":"F Arnold","year":"2026","unstructured":"Arnold, F., Del Vecchio, A., Hussain, Z. & Sherman, M. H. Heterocellular crosstalk and architecture of the pancreatic tumour microenvironment. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/s41568-025-00905-9 (2026).","journal-title":"Nat. Rev. Cancer"},{"key":"11002_CR5","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel, R. L., Kratzer, T. B., Wagle, N. S., Sung, H. & Jemal, A. Cancer statistics, 2026. CA 76, e70043 (2026).","journal-title":"CA"},{"key":"11002_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19288-6","volume":"11","author":"S Hamarsheh","year":"2020","unstructured":"Hamarsheh, S., Gross, O., Brummer, T. & Zeiser, R. Immune modulatory effects of oncogenic KRAS in cancer. Nat. Commun. 11, 5439 (2020).","journal-title":"Nat. Commun."},{"key":"11002_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s43018-023-00526-x","volume":"4","author":"S Barthel","year":"2023","unstructured":"Barthel, S., Falcomat\u00e0, C., Rad, R., Theis, F. J. & Saur, D. Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy. Nat Cancer 4, 454\u2013467 (2023).","journal-title":"Nat Cancer"},{"key":"11002_CR8","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1038\/s41588-024-01914-4","volume":"56","author":"AM Khaliq","year":"2024","unstructured":"Khaliq, A. M. et al. Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity. Nat. Genet. 56, 2455\u20132465 (2024).","journal-title":"Nat. Genet."},{"key":"11002_CR9","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/s41588-024-01890-9","volume":"56","author":"C Shiau","year":"2024","unstructured":"Shiau, C. et al. Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment. Nat. Genet. 56, 2466\u20132478 (2024).","journal-title":"Nat. Genet."},{"key":"11002_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01157-1","author":"D Cui Zhou","year":"2022","unstructured":"Cui Zhou, D. et al. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Nat. Genet. https:\/\/doi.org\/10.1038\/s41588-022-01157-1 (2022).","journal-title":"Nat. Genet."},{"key":"11002_CR11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","volume":"54","author":"WL Hwang","year":"2022","unstructured":"Hwang, W. L. et al. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Nat. Genet. 54, 1178\u20131191 (2022).","journal-title":"Nat. Genet."},{"key":"11002_CR12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.cell.2022.02.015","volume":"185","author":"M Dhainaut","year":"2022","unstructured":"Dhainaut, M. et al. Spatial CRISPR genomics identifies regulators of the tumor microenvironment. Cell 185, 1223\u20131239.e1220 (2022).","journal-title":"Cell"},{"key":"11002_CR13","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1016\/j.cell.2024.10.006","volume":"187","author":"G Mollaoglu","year":"2024","unstructured":"Mollaoglu, G. et al. Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell 187, 7492\u20137510.e7422 (2024).","journal-title":"Cell"},{"key":"11002_CR14","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s43018-020-00121-4","volume":"1","author":"NG Steele","year":"2020","unstructured":"Steele, N. G. et al. Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nat Cancer 1, 1097\u20131112 (2020).","journal-title":"Nat Cancer"},{"key":"11002_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/science.add5327","volume":"380","author":"C Burdziak","year":"2023","unstructured":"Burdziak, C. et al. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis. Science 380, eadd5327 (2023).","journal-title":"Science"},{"key":"11002_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","volume":"623","author":"N Caronni","year":"2023","unstructured":"Caronni, N. et al. IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer. Nature 623, 415\u2013422 (2023).","journal-title":"Nature"},{"key":"11002_CR17","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/0008-5472.CAN-19-2080","volume":"80","author":"S Das","year":"2020","unstructured":"Das, S., Shapiro, B., Vucic, E. A., Vogt, S. & Bar-Sagi, D. Tumor cell-derived IL-1\u03b2 promotes desmoplasia and immune suppression in pancreatic cancer. Cancer Res. 80, 1088\u20131101 (2020).","journal-title":"Cancer Res."},{"key":"11002_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","volume":"40","author":"A Alam","year":"2022","unstructured":"Alam, A. et al. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell 40, 153\u2013167 e111 (2022).","journal-title":"Cancer Cell"},{"key":"11002_CR19","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41586-020-03147-x","volume":"590","author":"D Alonso-Curbelo","year":"2021","unstructured":"Alonso-Curbelo, D. et al. A gene-environment-induced epigenetic program initiates tumorigenesis. Nature 590, 642\u2013648 (2021).","journal-title":"Nature"},{"key":"11002_CR20","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1158\/2159-8290.CD-20-1098","volume":"11","author":"JR Pitarresi","year":"2021","unstructured":"Pitarresi, J. R. et al. PTHrP drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability. Cancer Discov 11, 1774\u20131791 (2021).","journal-title":"Cancer Discov"},{"key":"11002_CR21","doi-asserted-by":"publisher","first-page":"e17144","DOI":"10.15252\/emmm.202217144","volume":"15","author":"MC Bouton","year":"2023","unstructured":"Bouton, M. C. et al. The under-appreciated world of the serpin family of serine proteinase inhibitors. EMBO Mol. Med. 15, e17144 (2023).","journal-title":"EMBO Mol. Med."},{"key":"11002_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-65811-y","volume":"16","author":"A Langtry","year":"2025","unstructured":"Langtry, A. et al. Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Nat. Commun. 16, 10769 (2025).","journal-title":"Nat. Commun."},{"key":"11002_CR23","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","volume":"156","author":"M Valiente","year":"2014","unstructured":"Valiente, M. et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 156, 1002\u20131016 (2014).","journal-title":"Cell"},{"key":"11002_CR24","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/s41591-020-1044-8","volume":"26","author":"RJ Motzer","year":"2020","unstructured":"Motzer, R. J. et al. Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial. Nat. Med. 26, 1733\u20131741 (2020).","journal-title":"Nat. Med."},{"key":"11002_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.trecan.2021.12.008","volume":"8","author":"A Galmiche","year":"2022","unstructured":"Galmiche, A., Rak, J., Roumenina, L. T. & Saidak, Z. Coagulome and the tumor microenvironment: an actionable interplay. Trends Cancer 8, 369\u2013383 (2022).","journal-title":"Trends Cancer"},{"key":"11002_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi, G. & Tuveson, D. A. Diversity and biology of cancer-associated fibroblasts. Physiol. Rev. 101, 147\u2013176 (2021).","journal-title":"Physiol. Rev."},{"key":"11002_CR27","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","volume":"186","author":"J Massague","year":"2023","unstructured":"Massague, J. & Sheppard, D. TGF-\u03b2 signaling in health and disease. Cell 186, 4007\u20134037 (2023).","journal-title":"Cell"},{"key":"11002_CR28","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0092-8674(00)81460-9","volume":"93","author":"SE Crawford","year":"1998","unstructured":"Crawford, S. E. et al. Thrombospondin-1 is a major activator of TGF-\u03b21 in vivo. Cell 93, 1159\u20131170 (1998).","journal-title":"Cell"},{"key":"11002_CR29","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1172\/JCI20741","volume":"113","author":"MJ Flick","year":"2004","unstructured":"Flick, M. J. et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor \u03b1M\u03b22\/Mac-1 is critical for host inflammatory response in vivo. J. Clin. Invest. 113, 1596\u20131606 (2004).","journal-title":"J. Clin. Invest."},{"key":"11002_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1126\/science.ade2292","volume":"381","author":"R Bill","year":"2023","unstructured":"Bill, R. et al. CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science 381, 515\u2013524 (2023).","journal-title":"Science"},{"key":"11002_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","volume":"26","author":"IG House","year":"2020","unstructured":"House, I. G. et al. Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade. Clin. Cancer Res. 26, 487\u2013504 (2020).","journal-title":"Clin. Cancer Res."},{"key":"11002_CR32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ccell.2026.01.020","volume":"44","author":"X Sun","year":"2026","unstructured":"Sun, X., Park, M. D., Merad, M. & Brown, B. D. Macrophages: targets for next-generation cancer immunotherapy. Cancer Cell 44, 498\u2013518 (2026).","journal-title":"Cancer Cell"},{"key":"11002_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41586-025-08927-x","volume":"642","author":"G Pei","year":"2025","unstructured":"Pei, G. et al. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. Nature 642, 212\u2013221 (2025).","journal-title":"Nature"},{"key":"11002_CR34","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.ccell.2025.06.020","volume":"43","author":"MM Chen","year":"2025","unstructured":"Chen, M. M. et al. Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer. Cancer Cell 43, 1656\u20131676.e1610 (2025).","journal-title":"Cancer Cell"},{"key":"11002_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36296-4","volume":"14","author":"G Werba","year":"2023","unstructured":"Werba, G. et al. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nat. Commun. 14, 797 (2023).","journal-title":"Nat. Commun."},{"key":"11002_CR36","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500\u2013503 (2011).","journal-title":"Nat. Med."},{"key":"11002_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","volume":"16","author":"EA Collisson","year":"2019","unstructured":"Collisson, E. A., Bailey, P., Chang, D. K. & Biankin, A. V. Molecular subtypes of pancreatic cancer. Nat. Rev. Gastroenterol. Hepatol. 16, 207\u2013220 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"11002_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"MH Sherman","year":"2023","unstructured":"Sherman, M. H. & Beatty, G. L. Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance. Annu. Rev. Pathol. 18, 123\u2013148 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"11002_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox, T. R. The matrix in cancer. Nat. Rev. Cancer 21, 217\u2013238 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"11002_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aea6734","volume":"12","author":"T Ngodup","year":"2026","unstructured":"Ngodup, T. et al. A stromal PAI1-tPA axis orchestrates immunosuppression in pancreatic cancer. Sci. Adv. 12, eaea6734 (2026).","journal-title":"Sci. Adv."},{"key":"11002_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-019-0510-x","volume":"121","author":"E Campello","year":"2019","unstructured":"Campello, E., Ilich, A., Simioni, P. & Key, N. S. The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues. Br. J. Cancer 121, 359\u2013371 (2019).","journal-title":"Br. J. Cancer"},{"key":"11002_CR42","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00262-020-02739-w","volume":"70","author":"Z Saidak","year":"2021","unstructured":"Saidak, Z. et al. A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment. Cancer Immunol. Immunother. 70, 923\u2013933 (2021).","journal-title":"Cancer Immunol. Immunother."},{"key":"11002_CR43","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/1097-0142(19920615)69:12<2884::AID-CNCR2820691204>3.0.CO;2-S","volume":"69","author":"A Andren-Sandberg","year":"1992","unstructured":"Andren-Sandberg, A., Lecander, I., Martinsson, G. & Astedt, B. Peaks in plasma plasminogen activator inhibitor-1 concentration may explain thrombotic events in cases of pancreatic carcinoma. Cancer 69, 2884\u20132887 (1992).","journal-title":"Cancer"},{"key":"11002_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb9200","author":"M Rossi Sebastiano","year":"2020","unstructured":"Rossi Sebastiano, M. et al. ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression. Sci. Adv. https:\/\/doi.org\/10.1126\/sciadv.abb9200 (2020).","journal-title":"Sci. Adv."},{"key":"11002_CR45","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41590-018-0232-x","volume":"19","author":"JK Ryu","year":"2018","unstructured":"Ryu, J. K. et al. Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat. Immunol. 19, 1212\u20131223 (2018).","journal-title":"Nat. Immunol."},{"key":"11002_CR46","doi-asserted-by":"publisher","unstructured":"Yan, Z. et al. Resilience to neuronal hyperactivity and restoration of the neuroimmune interactome by blocking fibrin-induced microglia activation in Alzheimers disease. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.05.01.722077 (2026).","DOI":"10.64898\/2026.05.01.722077"},{"key":"11002_CR47","doi-asserted-by":"publisher","unstructured":"Schmitt, C., Saur, D., Barthel, S. & Falcomata, C. Syngeneic mouse orthotopic allografts to model pancreatic cancer. J. Vis. Exp. https:\/\/doi.org\/10.3791\/64253 (2022).","DOI":"10.3791\/64253"},{"key":"11002_CR48","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168\u20131178 (2015).","journal-title":"Nat. Genet."},{"key":"11002_CR49","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","volume":"155","author":"F Puleo","year":"2018","unstructured":"Puleo, F. et al. Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features. Gastroenterology 155, 1999\u20132013.e1993 (2018).","journal-title":"Gastroenterology"},{"key":"11002_CR50","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1158\/0008-5472.CAN-15-2841","volume":"76","author":"S Yang","year":"2016","unstructured":"Yang, S. et al. A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2. Cancer Res. 76, 3838\u20133850 (2016).","journal-title":"Cancer Res."},{"key":"11002_CR51","doi-asserted-by":"publisher","first-page":"e31507","DOI":"10.1371\/journal.pone.0031507","volume":"7","author":"G Zhang","year":"2012","unstructured":"Zhang, G. et al. DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PLoS ONE 7, e31507 (2012).","journal-title":"PLoS ONE"},{"key":"11002_CR52","doi-asserted-by":"publisher","first-page":"113434","DOI":"10.1016\/j.celrep.2023.113434","volume":"42","author":"Y Ohara","year":"2023","unstructured":"Ohara, Y. et al. SERPINB3\u2013MYC axis induces the basal-like\/squamous subtype and enhances disease progression in pancreatic cancer. Cell Rep. 42, 113434 (2023).","journal-title":"Cell Rep."},{"key":"11002_CR53","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bau012","volume":"2014","author":"JX Binder","year":"2014","unstructured":"Binder, J. X. et al. COMPARTMENTS: unification and visualization of protein subcellular localization evidence. Database 2014, bau012 (2014).","journal-title":"Database"},{"key":"11002_CR54","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.cell.2018.09.022","volume":"175","author":"A Wroblewska","year":"2018","unstructured":"Wroblewska, A. et al. Protein barcodes enable high-dimensional single-cell CRISPR screens. Cell 175, 1141\u20131155.e1116 (2018).","journal-title":"Cell"},{"key":"11002_CR55","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"11002_CR56","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"11002_CR57","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nmeth.2078","volume":"9","author":"G Mullokandov","year":"2012","unstructured":"Mullokandov, G. et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat. Methods 9, 840\u2013846 (2012).","journal-title":"Nat. Methods"},{"key":"11002_CR58","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41586-025-09493-y","volume":"646","author":"S Hegde","year":"2025","unstructured":"Hegde, S. et al. Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours. Nature 646, 1214\u20131222 (2025).","journal-title":"Nature"},{"key":"11002_CR59","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nprot.2015.020","volume":"10","author":"ER Zunder","year":"2015","unstructured":"Zunder, E. R. et al. Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm. Nat. Protoc. 10, 316\u2013333 (2015).","journal-title":"Nat. Protoc."},{"key":"11002_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaf6925","volume":"1","author":"R Remark","year":"2016","unstructured":"Remark, R. et al. In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide. Sci. Immunol. 1, aaf6925 (2016).","journal-title":"Sci. Immunol."},{"key":"11002_CR61","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41592-021-01358-2","volume":"19","author":"G Palla","year":"2022","unstructured":"Palla, G. et al. Squidpy: a scalable framework for spatial omics analysis. Nat. Methods 19, 171\u2013178 (2022).","journal-title":"Nat. Methods"},{"key":"11002_CR62","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31657","volume":"7","author":"JR Lin","year":"2018","unstructured":"Lin, J. R. et al. Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes. eLife 7, e31657 (2018).","journal-title":"eLife"},{"key":"11002_CR63","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cell.2022.12.028","volume":"186","author":"JR Lin","year":"2023","unstructured":"Lin, J. R. et al. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer. Cell 186, 363\u2013381.e319 (2023).","journal-title":"Cell"},{"key":"11002_CR64","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s43018-021-00326-1","volume":"3","author":"C Falcomat\u00e0","year":"2022","unstructured":"Falcomat\u00e0, C. et al. Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment. Nat. Cancer 3, 318\u2013336 (2022).","journal-title":"Nat. Cancer"},{"key":"11002_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/science.adn0327","volume":"386","author":"MD Park","year":"2024","unstructured":"Park, M. D. et al. Hematopoietic aging promotes cancer by fueling IL-1\u03b1-driven emergency myelopoiesis. Science 386, eadn0327 (2024).","journal-title":"Science"},{"key":"11002_CR66","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.ccell.2021.10.009","volume":"39","author":"AM Leader","year":"2021","unstructured":"Leader, A. M. et al. Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification. Cancer Cell 39, 1594\u20131609.e1512 (2021).","journal-title":"Cancer Cell"},{"key":"11002_CR67","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1016\/j.molcel.2021.10.013","volume":"81","author":"MJ Regner","year":"2021","unstructured":"Regner, M. J. et al. A multi-omic single-cell landscape of human gynecologic malignancies. Mol. Cell 81, 4924\u20134941.e4910 (2021).","journal-title":"Mol. Cell"},{"key":"11002_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02540-7","volume":"22","author":"JM Dempster","year":"2021","unstructured":"Dempster, J. M. et al. Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects. Genome Biol. 22, 343 (2021).","journal-title":"Genome Biol."},{"key":"11002_CR69","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian, J. et al. Toil enables reproducible, open source, big biomedical data analyses. Nat. Biotechnol. 35, 314\u2013316 (2017).","journal-title":"Nat. Biotechnol."},{"key":"11002_CR70","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. 38, 675\u2013678 (2020).","journal-title":"Nat. Biotechnol."},{"key":"11002_CR71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s42003-023-04461-6","volume":"6","author":"LA Torre-Healy","year":"2023","unstructured":"Torre-Healy, L. A. et al. Open-source curation of a pancreatic ductal adenocarcinoma gene expression analysis platform (pdacR) supports a two-subtype model. Commun. Biol. 6, 163 (2023).","journal-title":"Commun. Biol."},{"key":"11002_CR72","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"11002_CR73","doi-asserted-by":"publisher","unstructured":"Falcomat\u00e0, C. A serpin-myeloid axis in pancreatic cancer heterogeneity and immune evasion (version v1) [Data set]. Zenodo https:\/\/doi.org\/10.5281\/zenodo.18882157 (2026).","DOI":"10.5281\/zenodo.18882157"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11002-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11002-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11002-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:45:00Z","timestamp":1793202300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11002-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":73,"journal-issue":{"issue":"8138","published-print":{"date-parts":[[2026,10,29]]}},"alternative-id":["11002"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-11002-8","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.D.B. has a patent application on the Pro-Codes (PCT\/US2018\/047996), which have been licensed to Immunai and Noetik. M.D. is a current employee of Noetik. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}